Search for Clinical Trial Results

Choroidal Neovascularization - 17 Studies Found
Status | Study |
Recruiting |
Study Name: AVENUE: A Proof-of-Concept Study of RG7716 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) Condition: Macular Degeneration, Choroidal Neovascularization Date: 2015-06-12 Interventions:
|
Completed |
Study Name: Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Condition:
Date: 2007-02-16 Interventions:
|
Completed |
Study Name: A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. Condition: Choroidal Neovascularization Secondary to Pathologic Myopia Date: 2014-01-09 Interventions: Drug: Ranibizumab All patients will receive a single initial intravitreal injection of ranibizumab 0.5 m |
Completed |
Study Name: Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration Condition:
Date: 1999-11-03 Interventions: Drug: Corticosteroid |
Completed |
Study Name: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO Condition: Choroidal Neovascularization, Age-related Macular Degeneration Date: 2006-09-21 Interventions: Drug: Ranibizumab 0.5 mg Ranibizumab intravitreal injection 0.5 mg in a single-dose regimen given on an |
Terminated |
Study Name: Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) Condition:
Date: 2007-02-08 Interventions:
|
Recruiting |
Study Name: Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients Condition: Idiopathic Choroidal Neovascularization Date: 2014-10-02 Interventions: Drug: aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o |